MiNK Therapeutics, Inc. (NASDAQ: INKT), a clinical-stage biopharmaceutical company pioneering allogeneic invariant natural killer T (allo-iNKT) cell therapies to restore immune balance ...

AI-driven tools are reshaping software development, empowering non-coders to thrive in entrepreneurship. The tech industry is ...

Cisco’s widely deployed Catalyst 9300 Series enterprise switches have four security vulnerabilities, two of which could be ...

The world's most popular CMS has been remade with the help of AI. Cloudflare has released EmDash version 0.1, described as a ...

Context Therapeutics Inc. (“Context” or the “Company”) (Nasdaq: CNTX), a clinical-stage biopharmaceutical company advancing T cell engaging (“TCE”) bispecific antibodies for solid tumors, ...

Anthropic says it accidentally leaked the source code for Claude Code, which is closed source, but the company says no ...

The manifesto did not say who in primary care would see an individual within 48 hours - whether that is a GP, a nurse or ...

Donald Trump had barely left the tarmac at Dover Air Base, a president in mournful respect for America's fallen, when his ...

Having worked across several sides of the insurance industry, Humana’s Richard Moore brings a well-rounded perspective to ...

Between March 24-26, president and chief executive officer Derek Sutherland sold a total of 25,000 shares at an average price per share of approximately $22.55 with 675,000 shares remaining in this ...

In this latest contribution to our 'In Focus' series, Edward Durell of Cover Direct examines how protection planning fits ...

Graceful constraint handling is a third path. It requires the agent to hold multiple things simultaneously: a model of what ...